Corton Capital Inc. Abbott Laboratories Transaction History

Corton Capital Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $342,797 - $378,604	-3,130 Reduced 46.23%	3,641 $413,000
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $26,425 - $32,347	293 Added 4.52%	6,771 $745,000
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $51,204 - $61,436	-536 Reduced 7.64%	6,478 $627,000
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $46,157 - $51,428	458 Added 6.99%	7,014 $764,000
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $38,453 - $45,261	397 Added 6.45%	6,556 $663,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $481,383 - $564,737	-5,064 Reduced 45.12%	6,159 $676,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $105,081 - $121,664	-1,086 Reduced 8.82%	11,223 $1.09 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $283,550 - $342,721	2,778 Added 29.15%	12,309 $1.34 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $370,793 - $452,158	-3,252 Reduced 25.44%	9,531 $1.13 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $1.48 Million - $1.81 Million	12,783 New	12,783 $1.8 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.